MAIA Biotechnology, Inc. Statistics
Want to see MAIA full AI Analyst Report?
MAIA Biotechnology, Inc. (MAIA) Stock Statistics & Valuation Metrics
Total Valuation
MAIA Biotechnology, Inc. has a market cap or net worth of $64.84M. The enterprise value is $45.84T.
- Market Cap
- $64.84M
- Enterprise Value
- $45.84T
Share Statistics
MAIA Biotechnology, Inc. has 61,750,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 61,750,310
- Owned by Insiders
- 8.83%
- Owned by Institutions
- 9.08%
Financial Efficiency
MAIA Biotechnology, Inc.’s return on equity (ROE) is -9.43 and return on invested capital (ROIC) is -627.41%.
- Return on Equity (ROE)
- -9.43
- Return on Assets (ROA)
- -2.31
- Return on Invested Capital (ROIC)
- -627.41%
- Return on Capital Employed (ROCE)
- -6.27
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.72M
- Employee Count
- 13
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of MAIA Biotechnology, Inc. is -2.17. MAIA Biotechnology, Inc.’s PEG ratio is -0.05.
- PE Ratio
- -2.17
- PS Ratio
- 0.00
- PB Ratio
- 4.36
- Price to FCF
- -2.55
- Price to Operating Cash Flow
- -2.52
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, MAIA Biotechnology, Inc. had revenue of 0 and earned -22.40M in profits. Earnings per share was -0.70.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -24.27M
- Pretax Income
- -22.40M
- Net Income
- -22.40M
- EBITDA
- -22.40M
- Earnings Per Share (EPS)
- -0.70
Cash Flow
In the last 12 months, operating cash flow was -25.39M and capital expenditures 0, giving a free cash flow of -25.39M billion.
- Operating Cash Flow
- -25.39M
- Free Cash Flow
- -25.39M
- Free Cash Flow per Share
- -0.42
Dividends & Yields
MAIA Biotechnology, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -37.05%
- Earnings Yield
- -37.18%
Stock Price Statistics
- Beta
- 1.61
- 52-Week Price Change
- -8.70%
- 50-Day Moving Average
- 1.21
- 200-Day Moving Average
- 1.41
- Relative Strength Index (RSI)
- 40.76
- Average Volume (3m)
- 448.57K
Financial Position
MAIA Biotechnology, Inc. as a current ratio of 1.66, with Debt / Equity ratio of 0.00%
- Current Ratio
- 1.66
- Quick Ratio
- 1.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 386.59
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, MAIA Biotechnology, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
MAIA Biotechnology, Inc. EV to EBITDA ratio is -1.84, with an EV/FCF ratio of -1.86.
- EV to Sales
- 0.00
- EV to EBITDA
- -1.84
- EV to Free Cash Flow
- -1.86
- EV to Operating Cash Flow
- -1.86
Balance Sheet
MAIA Biotechnology, Inc. has $21.34M in cash and marketable securities with $0.00 in debt, giving a net cash position of $21.34M billion.
- Cash & Marketable Securities
- $21.34M
- Total Debt
- $0.00
- Net Cash
- $21.34M
- Net Cash Per Share
- $0.35
- Tangible Book Value Per Share
- $0.24
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for MAIA Biotechnology, Inc. is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $14.00
- Price Target Upside
- 1233.33% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 35.05%
Scores
- Smart Score
- 4
- AI Score
- 44
